Updated use of first-line chemotherapy for advanced pancreatic cancer: FOLFIRINOX versus gemcitabine.
Thomas H. Cartwright
Consultant or Advisory Role - Amgen; Genentech; Lilly; Sanofi
Honoraria - Amgen; Lilly; Roche; Sanofi
Aimee Ginsburg Arlen
No relevant relationships to disclose
Lalan S. Wilfong
No relevant relationships to disclose
Robyn K. Harrell
No relevant relationships to disclose
J. Russell Hoverman
Employment or Leadership Position - US Oncology/McKesson Specialty Health
Roy A. Beveridge
Employment or Leadership Position - US Oncology/McKesson Specialty Health